The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
Open accessPublished version of a preprint
Abstract
Purpose: Oncogene mutations contribute to colorectal cancer development. We searched for differences in oncogene mutation profiles between colorectal cancer metastases from different sites and evaluated these as markers for site of relapse. Experimental Design: One hundred colorectal cancer metastases were screened for mutations in 19 oncogenes, and further 61 metastases and 87 matched primary cancers were analyzed for genes with identified mutations. Mutation prevalence was compared between (a) metastases from liver (n = 65), lung (n = 50), and brain (n = 46), (b) metastases and matched primary cancers, and (c) metastases and an independent cohort of primary cancers (n = 604). Mutations differing between metastasis sites were evaluated as markers for site of relapse in 859 patients from the VICTOR trial. Results: In colorectal cancer metastases, mutations were detected in 4 of 19 oncogenes: BRAF (3.1%), KRAS (48.4%), NRAS (6.2%), and PIK3CA (16.1%). KRAS mutation prevalence was significantly higher in lung (62.0%) and brain (56.5%) than in liver metastases (32.3%; P = 0.003). Mutation status was highly concordant between primary cancer and metastasis from the same individual. Compared with independent primary cancers, KRAS mutations were more common in lung and brain metastases (P < 0.005), but similar in liver metastases. Correspondingly, KRAS mutation was associated with lung relapse (HR = 2.1; 95% CI, 1.2 to 3.5, P = 0.007) but not liver relapse in patients from the VICTOR trial. Conclusions: KRAS mutation seems to be associated with metastasis in specific sites, lung and brain, in colorectal cancer patients. Our data highlight the potential of somatic mutations for informing surveillance strategies. Clin Cancer Res; 17(5); 1122–30. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although RAS mutations have been associated with increased tendency for lung involvement in colorectal cancer (33–35).”
From Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,809
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. C. (1996) · Journal of Computational and Graphical Statistics · doi:10.2307/1390807 · Cited by 4,245
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Lièvre, A., Bachet, J.-B., Le Corre, D., Boige, V., Landi, B., Emile, J.-F., Côté, J.-F., Tomasic, G., Penna, C., Ducreux, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0191 · Cited by 2,229
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., BOOM, J. H. V., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
Cited by
Sorted by citations
Items 201–217 of 217
Additional file 2 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624574
Additional file 1 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624568
Additional file 7 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624598
Additional file 6 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624589
Additional file 4 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624583
Additional file 8 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624601
Additional file 9 of Identification of hub genes and pathways in lung metastatic colorectal cancer
Dai, W., Guo, C., Wang, Y., Li, Y., Xie, R., Wu, J., Yao, B., Xie, D., He, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624604
Liang, Y., Ma, Z., Zhong, S., Zheng, Z., He, M., He, M., Liu, Y., Liu, Y., Deng, C., Huang, J., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1733538
Leclerc, A., Charles, M., Lesueur, P., Dupont, B., Emery, É., & Alvès, A. (2026) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2025.12.001
Kanemitsu, K., Hayashi, H., Tagayasu, Y., Tanizaki, T., Adach, Y., Ofuchi, T., Tajiri, T., Kitano, Y., Okabe, H., & Iwatsuki, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9008145/v1
Balogoun, R. (2019) · theses.fr (ABES) · doi:10.70675/b078c676z06b0z4093za0f0zf4b5ac1484fb
Ahmed, N., Chavda, V. K., & Hossain, M. N. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1772072
Kanemitsu, K., Hayashi, H., Tagayasu, Y., Tanizaki, T., Adachi, Y., Ofuchi, T., Tajiri, T., Kitano, Y., Okabe, H., & Iwatsuki, M. (2026) · Surgery Today · doi:10.1007/s00595-026-03377-y
Predicting Mutations and Metastases in Colorectal Tumors Using Artificial Intelligence
Idrissi, S. E., Drider, Y., Ouahab, I. B. A., Bouhorma, M., & Elouaai, F. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-21200-9_19
Zhang, L., Wang, J., Wan, J., Wang, Y., Zhang, H., Wang, Y., Xia, F., Shen, L., & Zhang, Z. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261484310
Wang, X., Ding, L., Meng, W., Byrnes, E., Loo, S. K., Sun, S., Chen, L., Li, T., Wang, M.-T., Pennathur, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb9836
Metadata
- Authors
- Tie, J., Lipton, L., Desai, J., Gibbs, P., Jorissen, R. N., Christie, M., Drummond, K. J., Thomson, B. N. J., Usatoff, V., Evans, P. M., Pick, A. W., Knight, S., Carne, P. W. G., Berry, R., Polglase, A., McMurrick, P., Zhao, Q., Busam, D., Strausberg, R. L., Domingo, E., Tomlinson, I. P. M., Midgley, R., Kerr, D., & Sieber, O. M.
- Affiliations
- J. Craig Venter Institute (US)
- Authors' Affiliations: 1Ludwig Colon Cancer Initiative Laboratory, Ludwig Institute for Cancer Research; 2Faculty of Medicine, Dentistry and Health Sciences, Department of Surgery, University of Melbourne; 3Departments of Medical Oncology, 4Neurosurgery, and 5Surgery, Royal Melbourne Hospital, Parkville; 6Division of Surgical Oncology, Peter MacCallum Cancer Center, East Melbourne; 7Department of Surgery, Western Hospital, Footscray; 8Cabrini Monash University Department of Surgery, St Frances Xavier Cabrini Hospital, Malvern, Melbourne, Australia; 9J. Craig Venter Institute, Rockville, Maryland; 10Ludwig Institute for Cancer Research, New York, New York; 11Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics and 12Department of Clinical Pharmacology, University of Oxford, Oxford, United Kingdom
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2011-03-01
- Volume
- 17
- Issue
- 5
- Pages
- 1122-1130
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2038202392
- Cited by
- 217
- References
- 50
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 9 · 2023: 18 · 2022: 7 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 11 · 2017: 19 · 2016: 15 · 2015: 21 · 2014: 20 · 2013: 16 · 2012: 21
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- KRAS mutation, colorectal cancer, lung metastasis, liver metastasis, brain metastases, oncogenic mutations, BRAF, NRAS, PIK3CA, curative resection, somatic mutations, surveillance strategy
- MeSH terms
- Brain Neoplasms, Colonic Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Mutation, Neoplasm Recurrence, Local, Proto-Oncogene Proteins, Genes, ras, Biomarkers, Tumor, Proto-Oncogene Proteins p21(ras), ras Proteins, Phosphatidylinositol 3-Kinases, Gene Expression Profiling, Proto-Oncogene Proteins B-raf, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
